DAF-3 is unique in that it is antagonized, rather than activated, by a TGF-beta pathway. In Caenorhabditis elegans (C.elegans), defects in a TGF-beta-related pathway cause a reversible developmental arrest and metabolic shift at the dauer larval stage. DAF-3 transgenes interfere with dauer formation, playing a role in the nucleus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Publications for DAF-3 Antibody (NB100-1924)(2)
We have publications tested in 1 confirmed species: C. elegans.
We have publications tested in 2 applications: ChIP, IP.